Kinarus Therapeutics (SIX: KNRS)

Last close As at 06/10/2025

0.00 (0.00%)

Market capitalisation

Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More

Healthcare | Flash note

Kinarus Therapeutics — Kinarus secures CHF1.5m financing

Healthcare | Flash note

Kinarus Therapeutics — USPTO allows method-of-use KIN001 patent

Healthcare | Flash note

Kinarus Therapeutics — KINETIC study discontinued

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free